 Josiane Broussard
Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Deprivation | 9 | 2023 | 166 | 3.600 |
Why?
| | Insulin Resistance | 15 | 2023 | 1072 | 2.470 |
Why?
| | Circadian Rhythm | 8 | 2023 | 354 | 2.070 |
Why?
| | Sleep | 10 | 2023 | 631 | 1.620 |
Why?
| | Obesity | 11 | 2023 | 2508 | 1.530 |
Why?
| | Insulin | 14 | 2023 | 2079 | 1.170 |
Why?
| | Muscle, Skeletal | 4 | 2021 | 1473 | 1.040 |
Why?
| | Fatty Acids, Nonesterified | 3 | 2015 | 151 | 0.960 |
Why?
| | Wakefulness | 1 | 2023 | 128 | 0.830 |
Why?
| | Dogs | 10 | 2020 | 334 | 0.800 |
Why?
| | Diet, High-Fat | 2 | 2020 | 225 | 0.750 |
Why?
| | Metabolic Diseases | 1 | 2022 | 98 | 0.730 |
Why?
| | Carnitine | 1 | 2021 | 62 | 0.720 |
Why?
| | Sleep Wake Disorders | 2 | 2016 | 233 | 0.720 |
Why?
| | Adipocytes | 2 | 2012 | 188 | 0.690 |
Why?
| | Hyperinsulinism | 3 | 2016 | 103 | 0.620 |
Why?
| | Insulin-Secreting Cells | 2 | 2020 | 317 | 0.620 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2017 | 84 | 0.570 |
Why?
| | Energy Metabolism | 3 | 2023 | 731 | 0.550 |
Why?
| | Chronobiology Disorders | 1 | 2016 | 12 | 0.540 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2016 | 37 | 0.520 |
Why?
| | Ghrelin | 1 | 2015 | 33 | 0.510 |
Why?
| | Eating | 3 | 2022 | 344 | 0.490 |
Why?
| | Glucose Clamp Technique | 7 | 2021 | 181 | 0.450 |
Why?
| | Glucose Tolerance Test | 5 | 2021 | 343 | 0.440 |
Why?
| | Lipid Metabolism | 2 | 2021 | 444 | 0.440 |
Why?
| | Heart Diseases | 1 | 2015 | 331 | 0.390 |
Why?
| | Random Allocation | 3 | 2020 | 335 | 0.390 |
Why?
| | Appetite | 2 | 2022 | 52 | 0.330 |
Why?
| | Blood Glucose | 9 | 2023 | 1828 | 0.310 |
Why?
| | Energy Intake | 3 | 2022 | 427 | 0.310 |
Why?
| | Dietary Fats | 3 | 2020 | 287 | 0.290 |
Why?
| | Oxidation-Reduction | 2 | 2021 | 923 | 0.290 |
Why?
| | Male | 18 | 2021 | 55596 | 0.280 |
Why?
| | Glucose Intolerance | 2 | 2020 | 136 | 0.260 |
Why?
| | Venoms | 2 | 2016 | 30 | 0.250 |
Why?
| | Animals | 13 | 2023 | 31706 | 0.240 |
Why?
| | Humans | 20 | 2023 | 114686 | 0.230 |
Why?
| | Portal Vein | 2 | 2014 | 76 | 0.220 |
Why?
| | Circadian Clocks | 1 | 2023 | 42 | 0.220 |
Why?
| | Hypoglycemic Agents | 3 | 2016 | 1013 | 0.210 |
Why?
| | Fasting | 2 | 2022 | 240 | 0.210 |
Why?
| | Gastrointestinal Microbiome | 2 | 2021 | 501 | 0.210 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2015 | 2096 | 0.200 |
Why?
| | Leptin | 2 | 2015 | 210 | 0.200 |
Why?
| | Homeostasis | 2 | 2023 | 573 | 0.190 |
Why?
| | Adult | 8 | 2023 | 30550 | 0.190 |
Why?
| | Body Weight | 4 | 2022 | 869 | 0.190 |
Why?
| | Citric Acid Cycle | 1 | 2021 | 43 | 0.180 |
Why?
| | Subcellular Fractions | 1 | 2021 | 78 | 0.180 |
Why?
| | Sphingolipids | 1 | 2021 | 57 | 0.180 |
Why?
| | Peptides | 2 | 2016 | 848 | 0.170 |
Why?
| | Mitochondria, Muscle | 1 | 2021 | 93 | 0.170 |
Why?
| | Meals | 1 | 2020 | 104 | 0.160 |
Why?
| | Health Status Disparities | 1 | 2021 | 200 | 0.160 |
Why?
| | Diet | 2 | 2015 | 1080 | 0.150 |
Why?
| | Young Adult | 5 | 2020 | 10469 | 0.150 |
Why?
| | Denervation | 2 | 2014 | 18 | 0.140 |
Why?
| | Norepinephrine | 2 | 2015 | 201 | 0.140 |
Why?
| | Adipose Tissue | 1 | 2020 | 545 | 0.140 |
Why?
| | Cross-Over Studies | 2 | 2023 | 440 | 0.140 |
Why?
| | Methyl Ethers | 1 | 2016 | 7 | 0.140 |
Why?
| | Isoflurane | 1 | 2016 | 8 | 0.140 |
Why?
| | Biomarkers | 3 | 2015 | 3408 | 0.140 |
Why?
| | Sex Characteristics | 1 | 2021 | 640 | 0.130 |
Why?
| | Hydrocortisone | 2 | 2015 | 267 | 0.130 |
Why?
| | Subcutaneous Fat | 1 | 2016 | 70 | 0.130 |
Why?
| | Fish Oils | 1 | 2015 | 21 | 0.130 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2015 | 21 | 0.130 |
Why?
| | Abdominal Fat | 1 | 2015 | 39 | 0.120 |
Why?
| | Dysbiosis | 1 | 2016 | 146 | 0.120 |
Why?
| | Human Growth Hormone | 1 | 2015 | 38 | 0.120 |
Why?
| | Feeding Behavior | 1 | 2020 | 574 | 0.120 |
Why?
| | Receptors, Glucagon | 1 | 2014 | 23 | 0.120 |
Why?
| | Healthy Volunteers | 1 | 2015 | 197 | 0.110 |
Why?
| | Intra-Abdominal Fat | 1 | 2014 | 77 | 0.110 |
Why?
| | Prediabetic State | 1 | 2016 | 219 | 0.110 |
Why?
| | Female | 7 | 2023 | 59507 | 0.100 |
Why?
| | Time Factors | 4 | 2020 | 6115 | 0.100 |
Why?
| | Polysomnography | 1 | 2012 | 135 | 0.100 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2015 | 358 | 0.100 |
Why?
| | Thinness | 1 | 2012 | 87 | 0.100 |
Why?
| | Up-Regulation | 1 | 2015 | 808 | 0.100 |
Why?
| | Lipids | 1 | 2015 | 580 | 0.090 |
Why?
| | Cohort Studies | 1 | 2021 | 4895 | 0.090 |
Why?
| | Hyperglycemia | 1 | 2014 | 292 | 0.090 |
Why?
| | Hemodynamics | 1 | 2015 | 1012 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2012 | 398 | 0.090 |
Why?
| | Adolescent | 4 | 2020 | 17844 | 0.080 |
Why?
| | Body Composition | 3 | 2020 | 590 | 0.080 |
Why?
| | Disease Models, Animal | 2 | 2016 | 3535 | 0.080 |
Why?
| | Sympathetic Nervous System | 1 | 2010 | 171 | 0.080 |
Why?
| | Hypoglycemia | 1 | 2014 | 387 | 0.080 |
Why?
| | Incidence | 1 | 2015 | 2313 | 0.080 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2012 | 195 | 0.080 |
Why?
| | Glucose | 3 | 2023 | 897 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 1842 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 2 | 2015 | 3052 | 0.070 |
Why?
| | Middle Aged | 3 | 2023 | 26737 | 0.070 |
Why?
| | Reaction Time | 1 | 2005 | 376 | 0.060 |
Why?
| | Memory | 1 | 2005 | 211 | 0.060 |
Why?
| | Liver | 3 | 2016 | 1637 | 0.060 |
Why?
| | ARNTL Transcription Factors | 1 | 2023 | 13 | 0.060 |
Why?
| | Postmenopause | 1 | 2023 | 303 | 0.050 |
Why?
| | Publications | 1 | 2021 | 37 | 0.050 |
Why?
| | Fitness Trackers | 1 | 2020 | 8 | 0.050 |
Why?
| | Health | 1 | 2021 | 74 | 0.050 |
Why?
| | Disease | 1 | 2021 | 85 | 0.040 |
Why?
| | Actigraphy | 1 | 2020 | 74 | 0.040 |
Why?
| | Signal Transduction | 1 | 2012 | 4513 | 0.040 |
Why?
| | Weight Gain | 1 | 2022 | 453 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1373 | 0.040 |
Why?
| | Gene Expression | 1 | 2023 | 1421 | 0.040 |
Why?
| | Data Collection | 1 | 2020 | 620 | 0.040 |
Why?
| | Anesthesia, Inhalation | 1 | 2016 | 4 | 0.030 |
Why?
| | Overweight | 1 | 2020 | 471 | 0.030 |
Why?
| | Sleep Stages | 1 | 2016 | 61 | 0.030 |
Why?
| | Propofol | 1 | 2016 | 43 | 0.030 |
Why?
| | Glucagon | 1 | 2016 | 92 | 0.030 |
Why?
| | Mental Health | 1 | 2021 | 562 | 0.030 |
Why?
| | Sympathectomy, Chemical | 1 | 2014 | 5 | 0.030 |
Why?
| | Omentum | 1 | 2014 | 8 | 0.030 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2014 | 13 | 0.030 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2014 | 68 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2014 | 139 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 2014 | 134 | 0.030 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2014 | 72 | 0.030 |
Why?
| | Organ Size | 1 | 2014 | 436 | 0.030 |
Why?
| | Catecholamines | 1 | 2014 | 94 | 0.030 |
Why?
| | Intestines | 1 | 2016 | 326 | 0.030 |
Why?
| | Models, Animal | 1 | 2014 | 344 | 0.030 |
Why?
| | Epinephrine | 1 | 2014 | 163 | 0.030 |
Why?
| | Pregnancy | 1 | 2023 | 5518 | 0.020 |
Why?
| | Infant | 1 | 2023 | 7963 | 0.020 |
Why?
| | Exercise | 1 | 2020 | 1644 | 0.020 |
Why?
| | Islets of Langerhans | 1 | 2014 | 726 | 0.020 |
Why?
| | Habituation, Psychophysiologic | 1 | 2005 | 48 | 0.020 |
Why?
| | Memory, Short-Term | 1 | 2005 | 225 | 0.010 |
Why?
| | Prospective Studies | 1 | 2012 | 6220 | 0.010 |
Why?
|
|
Broussard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|